You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
CNN reports approvals have been given to release more than 750 million genetically engineered mosquitoes in the Florida Keys.
New Scientist writes that researchers have genetically modified nerve cells to produce electrically functional polymers.
Zimbabwe, facing drought and possible famine, lifts its ban and imports genetically modified corn, according to Bloomberg.
CNN reports that a field test of genetically engineered diamondback moths show they act much like wild diamondback moths.
An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.
Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.
Ginkgo plans to strategically partner with leading companies in mature markets to create synthetic biology-based spinouts, something it has already done in ag-bio.
The Boston-based synthetic biology firm said it will use the funds to grow its cell programing platform, which it will make available to startups.
Researchers have genetically modified a fungus to kill malaria-spreading mosquitos, according to NPR.
The company launched last month with initial financing of $35 million and licenses to CRISPR and synthetic biology technology from the Broad and Harvard.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.